Literature DB >> 20190188

Uncertainty and patient heterogeneity in medical decision models.

Bas Groot Koerkamp1, Milton C Weinstein, Theo Stijnen, M H Heijenbrok-Kal, M G Myriam Hunink.   

Abstract

Parameter uncertainty, patient heterogeneity, and stochastic uncertainty of outcomes are increasingly important concepts in medical decision models. The purpose of this study is to demonstrate the various methods to analyze uncertainty and patient heterogeneity in a decision model. The authors distinguish various purposes of medical decision modeling, serving various stakeholders. Differences and analogies between the analyses are pointed out, as well as practical issues. The analyses are demonstrated with an example comparing imaging tests for patients with chest pain. For complicated analyses step-by-step algorithms are provided. The focus is on Monte Carlo simulation and value of information analysis. Increasing model complexity is a major challenge for probabilistic sensitivity analysis and value of information analysis. The authors discuss nested analyses that are required in patient-level models, and in nonlinear models for analyses of partial value of information analysis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20190188     DOI: 10.1177/0272989X09342277

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  34 in total

1.  Exploring Uncertainty in Economic Evaluations of Drugs and Medical Devices: Lessons from the First Review of Manufacturers' Submissions to the French National Authority for Health.

Authors:  Salah Ghabri; Françoise F Hamers; Jean Michel Josselin
Journal:  Pharmacoeconomics       Date:  2016-06       Impact factor: 4.981

2.  Economic analysis of nutrition interventions for chronic disease prevention: methods, research, and policy.

Authors:  John B Wong; Paul M Coates; Robert M Russell; Johanna T Dwyer; James A Schuttinga; Barbara A Bowman; Sarah A Peterson
Journal:  Nutr Rev       Date:  2011-09       Impact factor: 7.110

Review 3.  Sensitivity analysis in cost-effectiveness studies: from guidelines to practice.

Authors:  Rahul Jain; Michael Grabner; Eberechukwu Onukwugha
Journal:  Pharmacoeconomics       Date:  2011-04       Impact factor: 4.981

4.  Characterizing Heterogeneity Bias in Cohort-Based Models.

Authors:  Elamin H Elbasha; Jagpreet Chhatwal
Journal:  Pharmacoeconomics       Date:  2015-08       Impact factor: 4.981

5.  Economic evaluations with agent-based modelling: an introduction.

Authors:  Jagpreet Chhatwal; Tianhua He
Journal:  Pharmacoeconomics       Date:  2015-05       Impact factor: 4.981

6.  Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model.

Authors:  B Stollenwerk; T Bartmus; F Klug; S Stock; D Müller
Journal:  Osteoporos Int       Date:  2015-01-09       Impact factor: 4.507

Review 7.  A systematic and critical review of the evolving methods and applications of value of information in academia and practice.

Authors:  Lotte Steuten; Gijs van de Wetering; Karin Groothuis-Oudshoorn; Valesca Retèl
Journal:  Pharmacoeconomics       Date:  2013-01       Impact factor: 4.981

8.  A CTSA agenda to advance methods for comparative effectiveness research.

Authors:  Mark Helfand; Sean Tunis; Evelyn P Whitlock; Stephen G Pauker; Anirban Basu; Jon Chilingerian; Frank E Harrell; David O Meltzer; Victor M Montori; Donald S Shepard; David M Kent
Journal:  Clin Transl Sci       Date:  2011-06       Impact factor: 4.689

9.  A New MI-Based Visualization Aided Validation Index for Mining Big Longitudinal Web Trial Data.

Authors:  Zhaoyang Zhang; Hua Fang; Honggang Wang
Journal:  IEEE Access       Date:  2016-05-16       Impact factor: 3.367

10.  Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US.

Authors:  Pamela P Pei; Milton C Weinstein; X Cynthia Li; Michael D Hughes; A David Paltiel; Taige Hou; Robert A Parker; Melanie R Gaynes; Paul E Sax; Kenneth A Freedberg; Bruce R Schackman; Rochelle P Walensky
Journal:  HIV Clin Trials       Date:  2015-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.